Skip to main content
Top
Literature
Metadata
Title
The perspectives of molecularly targeted therapies which this issue illustrates
Author
Noriomi Matsumura
Publication date
01-07-2020
Publisher
Springer Singapore
Published in
International Cancer Conference Journal / Issue 3/2020
Electronic ISSN: 2192-3183
DOI
https://doi.org/10.1007/s13691-020-00423-5

Other articles of this Issue 3/2020

International Cancer Conference Journal 3/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine